Similar articles for PMID: 28751669

Year	Number of Results
1975	1
1979	1
1980	1
1983	1
1986	1
1993	1
1998	1
1999	3
2000	1
2001	2
2002	3
2004	3
2005	3
2006	3
2007	2
2008	5
2009	7
2010	7
2011	10
2012	5
2013	14
2014	10
2015	15
2016	7
2017	22
2018	37
2019	32
2020	19
2021	17
2022	13
2023	3
2024	1

1

In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.

Bialek-Davenet S, Mayer N, Vergalli J, Duprilot M, Brisse S, Pagès JM, Nicolas-Chanoine MH. Bialek-Davenet S, et al. Sci Rep. 2017 Jul 27;7(1):6722. doi: 10.1038/s41598-017-06503-6. Sci Rep. 2017. PMID: 28751669 Free PMC article.

2

High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. Kaczmarek FM, et al. Antimicrob Agents Chemother. 2006 Oct;50(10):3396-406. doi: 10.1128/AAC.00285-06. Antimicrob Agents Chemother. 2006. PMID: 17005822 Free PMC article.

3

Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.

Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y. Gröbner S, et al. J Med Microbiol. 2009 Jul;58(Pt 7):912-922. doi: 10.1099/jmm.0.005850-0. Epub 2009 Jun 5. J Med Microbiol. 2009. PMID: 19502377

4

Role of association of OmpK35 and OmpK36 alteration and bla_ESBL and/or bla_AmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae.

Hamzaoui Z, Ocampo-Sosa A, Fernandez Martinez M, Landolsi S, Ferjani S, Maamar E, Saidani M, Slim A, Martinez-Martinez L, Boutiba-Ben Boubaker I. Hamzaoui Z, et al. Int J Antimicrob Agents. 2018 Dec;52(6):898-905. doi: 10.1016/j.ijantimicag.2018.03.020. Epub 2018 Apr 2. Int J Antimicrob Agents. 2018. PMID: 29621592

5

Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.

Kim SY, Shin J, Shin SY, Ko KS. Kim SY, et al. Diagn Microbiol Infect Dis. 2013 Aug;76(4):486-90. doi: 10.1016/j.diagmicrobio.2013.04.006. Epub 2013 May 18. Diagn Microbiol Infect Dis. 2013. PMID: 23688521

6

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla_KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.

Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ. Shields RK, et al. Antimicrob Agents Chemother. 2017 Feb 23;61(3):e02097-16. doi: 10.1128/AAC.02097-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28031201 Free PMC article.

7

The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.

Wassef M, Abdelhaleim M, AbdulRahman E, Ghaith D. Wassef M, et al. Microb Drug Resist. 2015 Dec;21(6):577-80. doi: 10.1089/mdr.2014.0226. Epub 2015 May 6. Microb Drug Resist. 2015. PMID: 25945596

8

Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate.

Ma P, Laibinis HH, Ernst CM, Hung DT. Ma P, et al. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01281-18. doi: 10.1128/AAC.01281-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30126962 Free PMC article.

9

An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.

Hamzaoui Z, Ocampo-Sosa A, Maamar E, Fernandez Martinez M, Ferjani S, Hammami S, Harbaoui S, Genel N, Arlet G, Saidani M, Slim A, Boutiba-Ben Boubaker I, Martinez-Martinez L. Hamzaoui Z, et al. Microb Drug Resist. 2018 Oct;24(8):1137-1147. doi: 10.1089/mdr.2017.0165. Epub 2018 Jan 26. Microb Drug Resist. 2018. PMID: 29373087

10

Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.

Webster DP, Gaulton T, Woodford N, Pike R, Turton J, Perry C, Bowler IC. Webster DP, et al. Int J Antimicrob Agents. 2010 Dec;36(6):575-6. doi: 10.1016/j.ijantimicag.2010.08.003. Epub 2010 Sep 24. Int J Antimicrob Agents. 2010. PMID: 20869852 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

227 results

Results by year